Working… Menu

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02967679
Recruitment Status : Unknown
Verified November 2016 by MedDay Pharmaceuticals SA.
Recruitment status was:  Recruiting
First Posted : November 18, 2016
Last Update Posted : November 18, 2016
Information provided by (Responsible Party):
MedDay Pharmaceuticals SA

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2017
Study Completion Date : No date given